Blog

title-inside title-centered
2

Electric vehicles, revisited: Florida's future tech and people with disabilities

The recent article by Amy Keller within the May edition of Florida Trend was both illuminating and scary at the same time. Amy deserves a quick shout out for her article, “Future Shock.” I found it to be an excellent 50,000-foot  overview of the current use of electric vehicles (EVs) in Florida.

Older Adults and COVID: Still a Risk

You may recall my early blog entry when vaccines first became available to the public for COVID prevention:  https://isl.fsu.edu/article/youve-gotten-vaccine-can-life-now-return-normal.

Long-term effects of COVID-19 infection may shape cognitive health in an aging society

 

By Neil Charness, Ph.D., Director, Institute for Successful Longevity

Through designs and decisions, automakers are leaving behind persons with disabilities

Transportation innovation has been evolving significantly for at least 10 years. But this evolution of electric, automated, and on-demand services is leaving persons with disabilities (PWDs) and many older adults on the curb.

Two-Factor Authentication, revisited: How to transfer your digital information

I recently wrote about the need to plan ways to transfer your digital assets to heirs, particularly in light of the increased deployment of two-factor authentication

An end to the aging of the population? What the new numbers on life expectancy could mean

The Centers for Disease Control and Prevention and the National Center for Health Statistics recently released estimates for Life Expectancy at Birth in the United States for 2020: https://www.cdc.gov/nchs/data/vsrr/VSRR015-508.pdf.  As might be expected during the COVID-19 pandemic, the figures are grim.  We have lost about 1.5 years of life expectancy, with subgroups such as Latinos and African Americans experiencing even worse declines: 3 years and 2.9 years, respec

The controversy over Aduhelm – newest approved drug for Alzheimer’s disease — and why scientists are alarmed

You may have seen news stories about the controversy over the newest Alzheimer’s Disease drug, Aduhelm/aducanumab, recently approved by the Food and Drug Administration, https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug and later defended in a press release by the FDA after intense criticism:

Recent findings in mice suggest that Alzheimer’s disease may change brain function during sleep leading to memory loss and impairments in navigating our surroundings

Aaron Wilber, Ph.D., is Assistant Professor in the Department of Psychology and is affiliated with the Program in Neuroscience. He is a Faculty Affiliate of the Institute for Successful Longevity.